News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

ScinoPharm to Provide CMO Services for New Clinical Data Drug


2/17/2011 9:45:36 AM

February 17, 2011 -- ScinoPharm announced it will be the sole manufacturer for the active pharmaceutical ingredient of a new anti-depressant, Viibryd. ScinoPharm, a CRO/CMO headquartered in Taiwan, has research facilities in mainland China. The company implied it will make the API at its new GMP plant in Changshu, which is expected to be operational in Q3 of 2011. More details....

Read at ChinaBio Today


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES